Correlation Between C4 Therapeutics and Immunocore Holdings

Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between C4 Therapeutics and Immunocore Holdings, you can compare the effects of market volatilities on C4 Therapeutics and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Immunocore Holdings.

Diversification Opportunities for C4 Therapeutics and Immunocore Holdings

0.42

Correlation Coefficient

C4 Therapeutics  Immunocore Holdings

Very weak diversification

The 3 months correlation between CCCC and Immunocore is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Immunocore Holdings go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Immunocore Holdings

Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Immunocore Holdings. In addition to that, C4 Therapeutics is 2.44 times more volatile than Immunocore Holdings. It trades about -0.08 of its total potential returns per unit of risk. Immunocore Holdings is currently generating about -0.05 per unit of volatility. If you would invest  3,113  in Immunocore Holdings on September 28, 2024 and sell it today you would lose (247.00) from holding Immunocore Holdings or give up 7.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

C4 Therapeutics  vs.  Immunocore Holdings

C4 Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Immunocore Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with C4 Therapeutics and Immunocore Holdings

The main advantage of trading using opposite C4 Therapeutics and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.

The idea behind C4 Therapeutics and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.